Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Melanoma is added as a related topic, and MedlinePlus Genetics is listed under related topics to provide disease context and educational resources.
    Difference
    0.2%
    Check dated 2026-04-05T07:26:28.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Removed the core disease term 'Melanoma' and related topics; this reduces essential context for the study and may affect how users understand and locate the page.
    Difference
    0.2%
    Check dated 2026-03-21T20:28:02.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added links to related topics Melanoma and MedlinePlus Genetics in the study page's related topics section.
    Difference
    0.2%
    Check dated 2026-03-14T12:39:45.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Melanoma is removed from the related topics section. The site revision is updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-07T13:17:52.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added related topic links for Melanoma and MedlinePlus Genetics on the Study Details page.
    Difference
    0.2%
    Check dated 2026-02-21T03:51:04.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and removed Revision: v3.4.1 along with the topics Melanoma and related topics: MedlinePlus Genetics; these are metadata updates and do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T17:39:41.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.